Richard Meyer

The perils of empowered patients

8-2POST SUMMARY: Not only do patients have to worry about which drug company paid their physician, they need to determine if their generic drug is the same as the branded equivalent and if their insurance company will allow their doctor to write for a specific medication.  What is pharma doing to help patients navigate the complex world of empowered patient choices? Continue reading »

Friday News Headlines

headlinesToday, 42% of doctors practice as salaried employees of hospital systems, up from 24% in 2004, according to Cegedim Relationship Management, a marketing consultant.  As a result, the pharmaceutical industry is shifting its sales efforts from doctors to the institutions they work for. In 2005, drug companies employed about 102,000 U.S. sales representatives, who mostly pitch to doctors. By mid-2014, according to ZS Associates, a consulting firm, their numbers were down to about 63,000. Continue reading »

Is the FDA falling down on generics?

fridaynewsPOST SUMMARY: Eight out of 10 prescriptions written in the United States are filled with the no-brand name, generic version of the drug prescribed by a doctor.  The FDA mandates that generic forms of prescription medication contain the same active ingredient as the brand name, but the agency allows the generic version to use different inactive ingredients, including binders to hold the pill together and time release agents to disperse it. Continue reading »

Non adherence costs us all

adherencePOST SUMMARY: Low levels of adherence are extremely expensive.  The main take home point of a CVS Health study is that we need to look more closely at drug adherence in the community setting, not just for disease management, but for cost containment as well. Continue reading »

Share with your friends










Submit